278 related articles for article (PubMed ID: 18243635)
1. The prognosis of CMV retinitis among patients with AIDS in Serbia.
Dujić M; Jevtović Dj; Salemović D; Ranin J; Brmbolić B; Djurković-Djaković O
Biomed Pharmacother; 2008 Sep; 62(7):443-7. PubMed ID: 18243635
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
[TBL] [Abstract][Full Text] [Related]
4. Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis.
Martin BK; Ricks MO; Forman MS; Jabs DA;
Clin Infect Dis; 2007 Apr; 44(7):1001-8. PubMed ID: 17342657
[TBL] [Abstract][Full Text] [Related]
5. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
[TBL] [Abstract][Full Text] [Related]
6. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
[TBL] [Abstract][Full Text] [Related]
7. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
Ophthalmology; 2006 Aug; 113(8):1432-40. PubMed ID: 16766032
[TBL] [Abstract][Full Text] [Related]
8. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
Kempen JH; Martin BK; Wu AW; Barron B; Thorne JE; Jabs DA;
Ophthalmology; 2003 May; 110(5):987-95. PubMed ID: 12750102
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus retinitis and immune recovery uveitis in AIDS patients treated with highly active antiretroviral therapy in Taiwanese.
Lin YC; Yang CH; Lin CP; Yang CM; Chen MS; Chen MY; Sheng WH; Hung CC; Chang SC
Ocul Immunol Inflamm; 2008; 16(3):83-7. PubMed ID: 18569793
[TBL] [Abstract][Full Text] [Related]
10. [Digestive cytomegalovirus disease in AIDS patients].
Barberá JR; Capdevila JA; García-Quintana AM; Calicó I; Allende H; Ruiz I; Ocaña I; Pahissa A
Enferm Infecc Microbiol Clin; 1996; 14(7):411-5. PubMed ID: 8991434
[TBL] [Abstract][Full Text] [Related]
11. Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis.
Kappel PJ; Charonis AC; Holland GN; Narayanan R; Kulkarni AD; Yu F; Boyer DS; Engstrom RE; Kuppermann BD;
Ophthalmology; 2006 Apr; 113(4):683.e1-8. PubMed ID: 16581428
[TBL] [Abstract][Full Text] [Related]
12. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
Ophthalmology; 2006 Aug; 113(8):1441-5. PubMed ID: 16781775
[TBL] [Abstract][Full Text] [Related]
13. Ganciclovir implants: one year later.
Cadman J
GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
[TBL] [Abstract][Full Text] [Related]
14. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].
Mesarić B; Lisić M; Kniewald T; Ugrinović N; Begovac J
Lijec Vjesn; 2005; 127(5-6):123-8. PubMed ID: 16281473
[TBL] [Abstract][Full Text] [Related]
15. [Cystoid macular edema and cytomegalovirus retinitis in AIDS patients treated with antiretroviral triple therapy].
Badelon I; Gohier P; Chaine G
J Fr Ophtalmol; 1999 Dec; 22(10):1034-41. PubMed ID: 10617840
[TBL] [Abstract][Full Text] [Related]
16. Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome.
Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK; Tonascia J
Clin Infect Dis; 2003 Nov; 37(10):1365-73. PubMed ID: 14583871
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and outcomes of cytomegalovirus retinitis after transplantation.
Eid AJ; Bakri SJ; Kijpittayarit S; Razonable RR
Transpl Infect Dis; 2008 Feb; 10(1):13-8. PubMed ID: 17511815
[TBL] [Abstract][Full Text] [Related]
18. Association between cytomegalovirus-specific reactivity of T cell subsets and development of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
Hsieh SM; Pan SC; Hung CC; Tsai HC; Chen MY; Chang SC
J Infect Dis; 2001 Dec; 184(11):1386-91. PubMed ID: 11709780
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral therapy in AIDS patients with CMV disease: impact on the survival and long-term treatment outcome.
Sungkanuparph S; Chakriyanuyok T; Butthum B
J Infect; 2008 Jan; 56(1):40-3. PubMed ID: 18037166
[TBL] [Abstract][Full Text] [Related]
20. CMV after HAART.
Posit Aware; 1998; 9(5):18, 23. PubMed ID: 11365888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]